You are here: Home

Welcome to NORD

  • dia-carousel-register

  • physicians-guides-carousel

  • lulu-carousel

  • slide_003.jpg

  • liferaft-carousel

News and Events

orgs-fda

FDA and EMA to Co-Host Designation Workshop

FDA OOPD and its European counterpart will host an Orphan Designation and Grant workshop in Silver Spring, MD, on Oct. 12. Learn more about the meeting >

nih

Conference on Clinical Research for Rare Diseases

The NIH Rare Diseases Clinical Research Network and the Clinical and Translational Science Awards are sponsoring the 3rd Conference on Clinical Research for Rare Diseases on October 2 in Rockville, MD. Learn More >

nih

Christopher Austin to Serve as First NCATS Director

NIH Director Francis Collins has announced that Christopher Austin MD will serve as the first director of the National Center for Advancing Translational Sciences. Read more >

white-house

President Obama Signs FDASIA!

President Obama has signed into law a bill very important to rare disease patients. Read op-ed piece by NORD's president. >

Read NORD's press release >

News for Patients

ind-supreme

Where States Stand on the Medicaid Expansion

The US Supreme Court has ruled that states can effectively opt out of the ACA’s Medicaid expansion without any effect on current funding. American Health Line has compiled information about each state. More >

orgs-global

Lysosomal Storage Disorders Survey

A student researcher is conducting an interview study of adults with lysosomal storage disorders who have been involved in any clinical study or registry. Access the survey >

global-collaboration

Regional  Teleconference with CMS

CMS will be hosting a series of regional teleconferences in September to discuss Health Insurance Marketplace Exchanges and expanded insurance coverage options. More >

people-hearts

NBS Connect

NBS Connect is a new internet-based support network for parents, guardians and individuals with inborn errors of metabolism. Learn more >

News for Patient Organizations

burst-2

Share Information With NORD About Your Awareness Dates

NORD would like to promote awareness and support for disease-specific observances. Submit your information here>

hearts

NORD Organizational Membership Meeting in Philadelphia

Members should register now for NORD’s Regional Membership Meeting in Philadelphia on Friday, September 21st. Learn more >

orgs-fda

FDA OOPD Workshop on Pediatric Device Development

This free workshop will be held at the FDA's White Oak campus in Silver Spring, Maryland on Monday, September 24. Read more and register here >

patients-pnh

Gene for Alternating Hemiplegia of Childhood Identified

One of NORD's member organizations played a key role in identifying the gene for this disease.  Read more >

News for Medical Professionals

capitol

Proposed Legislation Would Bolster Reporting of Clinical Trial Data

The TEST Act would require all US biomedical studies on humans be registered on ClinicalTrials.gov and that the results be reported within one year. More>

patients-pnh

Conference on Clinical Research for Rare Diseases

The NIH Rare Diseases Clinical Research Network and the Clinical and Translational Science Awards are sponsoring the 3rd Conference on Clinical Research for Rare Diseases on October 2. More >

people-hearts

CRN Develops Resource for Cystinosis Treatment

Cystinosis Research Network develops standards of care resource for families and physicians. Read more >

nih

NIH Seeks Proposals to Study Genomic Sequencing in Newborn Period

The NIH is intending to fund projects to further the understanding of newborn on-set disorders and to improve treatments for these diseases. Read More >

News for Industry

orgs-global

NORD Board Members Honored by PharmaVoice

Two members of NORD's Board of Directors have been named to the "PharmaVoice 100". Read more >

med-rfp

Study Compares Oncology Drug Approvals and Costs

Tufts study finds oncology drugs approved more quickly in U.S. than in Europe but, in general, more costly. More >

org-challenges

FDA-NIH Science of Small Clinical Trials

This course will present an overall framework and provide training in the scientific aspects of designing and analyzing clinical trials based on small study populations. Read more>

burst-2

NORD's President Interviewed about Rare Disease R&D

NORD President Peter L. Saltonstall was interviewed recently by PharmaPhoroum. Read the article >

WHAT IS NORD?

The National Organization for Rare Disorders is dedicated to helping the nearly 30 million Americans with rare diseases, and the organizations that serve them, through programs of education, advocacy, research, and patient services. More >

NORD Get our latest e-news

 
Copyright ©2012 NORD - National Organization for Rare Disorders, Inc. All rights reserved.